false
0001538495
0001538495
2026-08-11
2026-08-11
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 11, 2026
Commission
File No. 000-55000
EARTH
SCIENCE TECH, INC.
(Exact
name of registrant as specified in its charter)
| florida |
|
45-4267181 |
| (State
or other jurisdiction of |
|
(I.R.S.
Employer |
| incorporation
or organization) |
|
Identification
No.) |
8950
SW 74th CT
Suite
1401
Miami,
FL 33156, USA
(Address
of principal executive offices, zip code)
(305)
724-5684
(Registrant’s
telephone number, including area code)
(Former
name, former address and former fiscal year, if changed since last report)
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of Each Class |
|
Trading
Symbol |
|
Name
of each exchange on which registered |
| Common
Stock $0.001 par value |
|
ETST |
|
Over
the Counter Bulletin Board |
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
8.01 Other Events
On
August 11, 2026, Earth Science Tech, Inc., a Florida corporation (the “Company”), entered into an agreement to acquire Meduvo
LLC, a California limited liability company. The terms are not disclosed due to the amount being immaterial.
Related
Party Transaction
Mario
G. Tabraue, who currently serves as the Company’s Chief Operations Officer and is a member of the Board of Directors, was the seller
in this transaction. Because Mr. Tabraue is a related person, the transaction was reviewed and approved by the independent members of
the Board of Directors to ensure that the terms were fair, reasonable, and no less favorable to the Company than those that could be
obtained from unaffiliated third parties.
Item
7.01 Regulation FD Disclosure
On
August 12, 2024, the Company issued a press release (the “Release”) announcing the acquisition of Meduvo LLC. A copy of the
Release is attached hereto as Exhibit 99.1.
The
information in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as expressly set
forth by specific reference in such filing.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits – The following exhibits are filed as part of this report:
| Exhibit
No. |
|
Description |
| 99.1 |
|
Press release issued by the registrant on August 12, 2026 |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
EARTH
SCIENCE TECH, INC. |
| |
|
|
| Dated:
August 12, 2026 |
By: |
/s/
Giorgio R. Saumat |
| |
|
Giorgio
R. Saumat |
| |
Its: |
CEO
and Chairman of the Board |
Exhibit
99.1
Earth
Science Tech, Inc. (ETST) Expands National Footprint with Strategic Acquisition of California Compounding Pharmacy, Meduvo LLC
MIAMI,
Aug. 12, 2026 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a
strategic holding company focused on a diversified portfolio, today announced the acquisition of Meduvo LLC, a compounding pharmacy based
in La Verne, California.
The
acquisition serves as an immediate growth catalyst, establishing a highly strategic West Coast operational hub and expanding ETST’s
network to 34 U.S. jurisdictions. Regulatory approvals for the remaining states are actively pending as the Company pursues full nationwide
coverage.
Currently
operating from a 2,000-square-foot facility, Meduvo compounds and dispenses, non-sterile medications. To capture broader market share
and unlock long-term, high-margin revenue streams, ETST is initiating facility upgrades to meet strict sterility requirements. Management
targets full regulatory certification for sterile compounding by the end of 2028.
With
the successful integration of Meduvo, ETST’s compounding pharmacies are now authorized to dispense across the following 34 territories:
Alabama, Arizona, California, Colorado, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Maine, Maryland, Massachusetts, Minnesota,
Mississippi, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Puerto Rico, Rhode Island, South Carolina,
South Dakota, Texas, Utah, Vermont, Virginia, Wisconsin, and Wyoming.
About
Earth Science Tech, Inc. (ETST)
Earth
Science Tech, Inc. operates as a diversified holding company focused on the health and wellness sector. The Company’s principal
operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine
platforms, clinical support, and direct-to-patient fulfillment. The Company’s healthcare operations are supported by investments
in real estate and asset management activities and a consumer products business.
The
core of the Company’s value proposition is the seamless integration of patient care, from consultation to fulfillment. This is
achieved through the synergy of specialized subsidiaries.
To
learn more, please visit: www.EarthScienceTech.com
Forward-Looking
Statements
Except
for historical information, the matters discussed herein may be considered “forward-looking” statements within the meaning
of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.
Such
statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without
limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and
reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions,
as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally
can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words
such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,”
“intend,” “belief,” “plan,” “estimate,” “target,” “predict,”
“likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,”
“forecast,” “outlook” or similar terminology. Forward-looking statements are subject to a number of risks and
uncertainties that may cause the Company’s actual results to differ materially from our intent, belief or current expectations,
including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government
regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should
underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company
assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.
Contact:
Hayden
IR
James
Carbonara
(646)-755-7412
james@haydenir.com
Brett
Maas
(646)
536-7331
brett@haydenir.com
